Skip to content

Research on Key Theories and Technologies for Smart Assessment, Decision-Making, and Comprehensive Evaluation of Newly Emerging Infectious Diseases

Research on Key Theories and Technologies for Smart Assessment, Decision-Making, and Comprehensive Evaluation of Newly Emerging Infectious Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128482
Enrollment
Unknown
Registered
2026-07-21
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Mpox, influenza, dengue fever, chikungunya fever, and avian influenza

Interventions

Control group:Routine infectious disease prevention and control model
Experimental group:Multi-agent integration toolkit for decision-making support

Sponsors

Peking University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The district/county/city where the participant's workplace is located has experienced at least one emerging or re-emerging infectious disease, including COVID-19, Mpox, influenza, dengue fever, chikungunya fever, and/or avian influenza. 2.The participant is currently responsible for or involved in epidemic prevention and control-related work at the district/county/municipal CDC level, including but not limited to infectious disease epidemic information collection, risk perception, risk assessment, deliberation and decision-making, risk management, and emergency response. 3.The participant voluntarily agrees to participate in this project.

Exclusion criteria

Exclusion criteria: 1.Age under 18 years. 2.Suffering from severe mental disorders or other conditions that impede normal communication. 3.Having worked in the current position for less than one year.

Design outcomes

Primary

MeasureTime frame
Response Time for Risk Assessment Report Generation and Submission;

Secondary

MeasureTime frame
Epidemic Control Effectiveness;Consistency of Risk Assessment Results between Multi-Agent Toolkit and Expert Panel;User Experience and Satisfaction with the Smart Toolkit;Social and Economic Benefits;

Countries

China

Contacts

Public ContactJue Liu

Peking University

jueliu@bjmu.edu.cn+86 10 82805146

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026